1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Aseel Alsouqi: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia | Phase 2 | Recruiting | Aseel Alsouqi | 24 | 2023-07-28 | 2026-03-03 |
Biopsy (1) · Cyclophosphamide (1) · Leukapheresis (1) · Magnetic Resonance Spectroscopy (1) · Sentinel Lymph Node Biopsy (1) · Specimen Handling (1) · fludarabine (1) · zanubrutinib (1)
United States (1)